Quantitative neuroimaging in mucopolysaccharidoses clinical trials

Molecular Genetics and Metabolism

Volumn 122, Issue , 2017, Pages 17-24

  Nestrasil, Igor ^a   Vedolin, Leonardo ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b DASA   (Brazil)

Author keywords

Diffusion tensor imaging; Lysosomal storage diseases; Magnetic resonance imaging; Mucopolysaccharidoses; Neuroimaging

Indexed keywords

CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL OUTCOME; DATA ANALYSIS SOFTWARE; DIFFUSION TENSOR IMAGING; HUMAN; MUCOPOLYSACCHARIDOSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SAMPLING; STUDY DESIGN; AGE; BRAIN; CHILD; CLINICAL TRIAL (TOPIC); CYTOLOGY; DEVICES; DIAGNOSTIC IMAGING; ENZYMOLOGY; GENETICS; IMAGE PROCESSING; LYSOSOME; METABOLISM; ORGANIZATION; PATHOLOGY; PATIENT SELECTION; PRACTICE GUIDELINE; PRESCHOOL CHILD; PROCEDURES; STANDARDS; TREATMENT OUTCOME; TRENDS;

GLYCOSAMINOGLYCAN;

AGE FACTORS; BRAIN; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; CONGRESSES AS TOPIC; DIFFUSION TENSOR IMAGING; GLYCOSAMINOGLYCANS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYSOSOMES; MAGNETIC RESONANCE IMAGING; MUCOPOLYSACCHARIDOSES; NEUROIMAGING; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 85032385010     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2017.09.006     Document Type: Review

References (61)

1. Muenzer, J., Overview of the mucopolysaccharidoses. Rheumatology (Oxford) 50:Suppl. 5 (2011), v4–v12.
2. Neufeld, E.F., Muenzer, J., The mucopolysaccharidoses. Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D., (eds.) The Metabolic and Molecular Bases of Inherited Disease, 2001, McGraw-Hill Medical Publishing Division, New York, 3421–3452.
3. Zafeiriou, D.I., Batzios, S.P., Brain and spinal MR imaging findings in mucopolysaccharidoses: a review. AJNR Am. J. Neuroradiol. 34 (2013), 5–13.
4. Węgrzyn, G., Jakóbkiewicz-Banecka, J., Narajczyk, M., Wiśniewski, A., Piotrowska, E., Gabig-Cimińska, M., Kloska, A., Słomińska-Wojewódzka, M., Korzon-Burakowska, A., Węgrzyn, A., Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?. Med. Hypotheses 75 (2010), 605–609.
5. Shapiro, E.G., Jones, S.A., Escolar, M.L., Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations - neurological signs and symptoms. Mol. Genet. Metab. 122 (2017), 1–7.
6. Bax, M.C.O., Colville, G.A., Behaviour in mucopolysaccharide disorders. Arch. Dis. Child. 73 (1995), 77–81.
7. Gilkes, J.A., Heldermon, C.D., Mucopolysaccharidosis III (Sanfilippo syndrome)- disease presentation and experimental therapies. Pediatr. Endocrinol. Rev. 12:Suppl. 1 (2014), 133–140.
8. Holt, J.B., Poe, M.D., Escolar, M.L., Natural progression of neurological disease in mucopolysaccharidosis type II. Pediatrics 127 (2011), e1258–1265.
9. Shapiro, E.G., Nestrasil, I., Rudser, K., Delaney, K., Kovac, V., Ahmed, A., Yund, B., Orchard, P.J., Eisengart, J., Niklason, G.R., Raiman, J., Mamak, E., Cowan, M.J., Bailey-Olson, M., Harmatz, P., Shankar, S.P., Cagle, S., Ali, N., Steiner, R.D., Wozniak, J., Lim, K.O., Whitley, C.B., Neurocognition across the spectrum of mucopolysaccharidosis type I: age, severity, and treatment. Mol. Genet. Metab. 116 (2015), 61–68.
10. Shapiro, E.G., Lockman, L.A., Balthazor, M., Krivit, W., Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J. Inherit. Metab. Dis. 18 (1995), 413–429.
11. Dekaban, A.S., Constantopoulos, G., Mucopolysaccharidosis type I, II, IIIA and V. Pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain. Acta Neuropathol. 39 (1977), 1–7.
12. Tomatsu, S., Gutierrez, M.A., Ishimaru, T., Peña, O.M., Montaño, A.M., Maeda, H., Velez-Castrillon, S., Nishioka, T., Fachel, A.A., Cooper, A., Thornley, M., Wraith, E., Barrera, L.A., Laybauer, L.S., Giugliani, R., Schwartz, I.V., Frenking, G.S., Beck, M., Kircher, S.G., Paschke, E., Yamaguchi, S., Ullrich, K., Isogai, K., Suzuki, Y., Orii, T., Noguchi, A., Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses. J. Inherit. Metab. Dis. 28 (2005), 743–757.
13. Muenzer, J., The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. J. Pediatr. 144:5 Suppl (2004), S27–S34.
14. Abramson, R.G., Burton, K.R., Yu, J.P.J., Scalzetti, E.M., Yankeelov, T.E., Rosenkrantz, A.B., Mendiratta-Lala, M., Bartholmai, B.J., Ganeshan, D., Lenchik, L., Subramaniam, R.M., Methods and challenges in quantitative imaging biomarker development. Acad. Radiol. 22 (2015), 25–32.
15. Buckler, A.J., Bresolin, L., Dunnick, N.R., Sullivan, D.C., Group, A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging. Radiology 258 (2011), 906–914.
16. Smith, J.J., Sorensen, A.G., Thrall, J.H., Biomarkers in imaging: realizing radiology's future. Radiology 227 (2003), 633–638.
17. Finn, C.T., Vedolin, L., Schwartz, I.V., Giugliani, R., Haws, C.A., Prescot, A.P., Renshaw, P.F., Magnetic resonance imaging findings in Hunter syndrome. Acta Paediatr. Suppl. 97 (2008), 61–68.
18. Lee, C., Dineen, T.E., Brack, M., Kirsch, J.E., Runge, V.M., The mucopolysaccharidoses: characterization by cranial MR imaging. AJNR Am. J. Neuroradiol. 14 (1993), 1285–1292.
19. Seto, T., Kono, K., Morimoto, K., Inoue, Y., Shintaku, H., Hattori, H., Matsuoka, O., Yamano, T., Tanaka, A., Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann. Neurol. 50 (2001), 79–92.
20. Gabrielli, O., Polonara, G., Regnicolo, L., Petroni, V., Scarabino, T., Coppa, G.V., Salvolini, U., Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses. Am. J. Med. Genet. A 125A (2004), 224–231.
21. Vedolin, L., Schwartz, I.V.D., Komlos, M., Schuch, A., Puga, A.C., Pinto, L.L.C., Pires, A.P., Giugliani, R., Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II. AJNR Am. J. Neuroradiol. 28 (2007), 1029–1033.
22. Azevedo, A.C.M., Artigalás, O., Vedolin, L., Komlós, M., Pires, A., Giugliani, R., Schwartz, I.V.D., Brain magnetic resonance imaging findings in patients with mucopolysaccharidosis VI. J. Inherit. Metab. Dis. 36 (2013), 357–362.
23. Ashton, E., Riek, J., Advanced MR techniques in multicenter clinical trials. J. Magn. Reson. Imaging 37 (2013), 761–769.
24. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Clinical Trial Imaging Endpoint Process Standards Guidance for Industry, 2015 http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm268555.pdf.
25. Rosenkrantz, A.B., Mendiratta-Lala, M., Bartholmai, B.J., Ganeshan, D., Abramson, R.G., Burton, K.R., Yu, J.P.J., Scalzetti, E.M., Yankeelov, T.E., Subramaniam, R.M., Lenchik, L., Clinical utility of quantitative imaging. Acad. Radiol. 22 (2015), 33–49.
26. Chalavi, S., Simmons, A., Dijkstra, H., Barker, G.J., Reinders, A.A., Quantitative and qualitative assessment of structural magnetic resonance imaging data in a two-center study. BMC Med. Imaging, 12, 2012, 27.
27. Glasser, M.F., Smith, S.M., Marcus, D.S., Andersson, J.L., Auerbach, E.J., Behrens, T.E., Coalson, T.S., Harms, M.P., Jenkinson, M., Moeller, S., Robinson, E.C., Sotiropoulos, S.N., Xu, J., Yacoub, E., Ugurbil, K., Van Essen, D.C., The Human Connectome Project's neuroimaging approach. Nat. Neurosci. 19 (2016), 1175–1187.
28. Walker, R., Belani, K.G., Braunlin, E.A., Bruce, I.A., Hack, H., Harmatz, P.R., Jones, S., Rowe, R., Solanki, G.A., Valdemarsson, B., Anaesthesia and airway management in mucopolysaccharidosis. J. Inherit. Metab. Dis. 36 (2013), 211–219.
29. Kundel, H.L., History of research in medical image perception. J. Am. Coll. Radiol. 3 (2006), 402–408.
30. Fischl, B., FreeSurfer. NeuroImage 62 (2012), 774–781.
31. Shapiro, E.G., Nestrasil, I., Delaney, K.A., Rudser, K., Kovac, V., Nair, N., Richard, C.W., III, P. Haslett, Whitley, C.B., A prospective natural history study of mucopolysaccharidosis type IIIA. J. Pediatr. 170 (2016), 278–287.
32. Yund, B., Rudser, K., Ahmed, A., Kovac, V., Nestrasil, I., Raiman, J., Mamak, E., Harmatz, P., Steiner, R., Lau, H., Vekaria, P., Wozniak, J.R., Lim, K.O., Delaney, K., Whitley, C., Shapiro, E.G., Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II. Mol. Genet. Metab. 114 (2015), 170–177.
33. Fan, Z., Styner, M., Muenzer, J., Poe, M., Escolar, M., Correlation of automated volumetric analysis of brain MR imaging with cognitive impairment in a natural history study of mucopolysaccharidosis II. AJNR Am. J. Neuroradiol. 31 (2010), 1319–1323.
34. Zuber, Z., Jurecka, A., Jurkiewicz, E., Kieć-Wilk, B., Tylki-Szymańska, A., Cervical spine MRI findings in patients with mucopolysaccharidosis type II. Pediatr. Neurosurg. 50 (2015), 26–30.
35. Borlot, F., Arantes, P.R., Quaio, C.R., Franco, J.F.D.S., Lourenco, C.M., Bertola, D.R., Kim, C.A., New insights in mucopolysaccharidosis type VI: neurological perspective. Brain Dev. 36 (2014), 585–592.
36. Vedolin, L., Schwartz, I.V.D., Komlos, M., Schuch, A., Azevedo, A.C., Vieira, T., Maeda, F.K., Marques da Silva, A.M., Giugliani, R., Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings. Neurology 69 (2007), 917–924.
37. Shapiro, E., Guler, O.E., Rudser, K., Delaney, K., Bjoraker, K., Whitley, C., Tolar, J., Orchard, P., Provenzale, J., Thomas, K., An exploratory study of brain function and structure in mucopolysaccharidosis type I: long term observations following hematopoietic cell transplantation (HCT). Mol. Genet. Metab. 107 (2012), 116–121.
38. Lampe, C., Lampe, C., Schwarz, M., Müller-Forell, W., Harmatz, P., Mengel, E., Craniocervical decompression in patients with mucopolysaccharidosis VI: development of a scoring system to determine indication and outcome of surgery. J. Inherit. Metab. Dis. 36 (2013), 1005–1013.
39. Svatkova, A., Pasternak, O., Rudser, K., Bednařík, P., Mueller, B.A., Wakumoto, A., Shapiro, E., Whitley, C., Nestrasil, I., Comprehensive white matter assessment in Mucopolysaccharidosis type I – a DTI study. 22nd Annual Meeting of the Organization for Human Brain Mapping, Geneva, Switzerland, June 2016.
40. Poptani, H., Kumar, M., Nasrallah, I.M., Kim, S., Ittyerah, R., Pickup, S., Li, J., Parente, M.K., Wolfe, J.H., High-resolution magnetic resonance microscopy and diffusion tensor imaging to assess brain structural abnormalities in the murine mucopolysaccharidosis VII model. J. Neuropathol. Exp. Neurol. 73 (2014), 39–49.
41. Palmucci, S., Attinà, G., Lanza, M.L., Belfiore, G., Cappello, G., Foti, P.V., Milone, P., Di Bella, D., Barone, R., Fiumara, A., Sorge, G., Ettorre, G.C., Imaging findings of mucopolysaccharidoses: a pictorial review. Insights Imaging 4 (2013), 443–459.
42. Matheus, M.G., Castillo, M., Smith, J.K., Armao, D., Towle, D., Muenzer, J., Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 46 (2004), 666–672.
43. Hughes, D.G., Chadderton, R.D., Cowie, R.A., Wraith, J.E., Jenkins, J.P.R., MRI of the brain and craniocervical junction in Morquio's disease. Neuroradiology 39 (1997), 381–385.
44. Kulkarni, M.V., Williams, J.C., Yeakley, J.W., Andrews, J.L., McArdle, C.B., Narayana, P.A., Howell, R.R., Jonas, A.J., Magnetic resonance imaging in the diagnosis of the cranio-cervical manifestations of the mucopolysaccharidoses. Magn. Reson. Imaging 5 (1987), 317–323.
45. Alden, T., Amartino, H., Dalla Corte, A., Lampe, C., Harmatz, P., Vedolin, L., Surgical management of neurological manifestations of mucopolysaccharidosis disorders. Mol. Genet. Metab. 122 (2017), 41–48.
46. Ng, S.E., Low, A.M.S., Tang, K.K., Chan, Y.H., Kwok, R.K., Value of quantitative MRI biomarkers (Evans' index, aqueductal flow rate, and apparent diffusion coefficient) in idiopathic normal pressure hydrocephalus. J. Magn. Reson. Imaging 30 (2009), 708–715.
47. Holodny, A.I., Waxman, R., George, A.E., Rusinek, H., Kalnin, A.J., de Leon, M., MR differential diagnosis of normal-pressure hydrocephalus and Alzheimer disease: significance of perihippocampal fissures. AJNR Am. J. Neuroradiol. 19 (1998), 813–819.
48. Solanki, G.A., Martin, K.W., Theroux, M.C., Lampe, C., White, K.K., Shediac, R., Lampe, C.G., Beck, M., Mackenzie, W.G., Hendriksz, C.J., Harmatz, P.R., Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management. J. Inherit. Metab. Dis. 36 (2013), 339–355.
49. Nestrasil, I., Ahmed, A., Kovac, V., Rudser, K., Delaney, K., Barbier, A., Whitley, C.B., Shapiro, E., Brain volumes and cognitive function in MPS IIIB (Sanfilippo syndrome type B): cross-sectional study. Mol. Genet. Metab., 114, 2015, S87.
50. Alexander, A.L., Lee, J.E., Lazar, M., Field, A.S., Diffusion tensor imaging of the brain. Neurotherapeutics 4 (2007), 316–329.
51. Provenzale, J.M., Nestrasil, I., Chen, S., Kan, S.H., Le, S.Q., Jens, J.K., Snella, E.M., Vondrak, K.N., Yee, J.K., Vite, C.H., Elashoff, D., Duan, L., Wang, R.Y., Ellinwood, N.M., Guzman, M.A., Shapiro, E.G., Dickson, P.I., Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I. Exp. Neurol. 273 (2015), 1–10.
52. Choi, J., Dickson, P., Calabrese, E., Chen, S., White, L., Ellingwood, M., Provenzale, J.M., Predicting degree of myelination based on diffusion tensor imagining of canines with mucopolysaccharidosis type I. Neuroradiol. J. 28 (2015), 562–573.
53. Nestrasil, I., Svatkova, A., Pasternak, O., Rudser, K., Bednarik, P., Mueller, B., Wakumoto, A., Shapiro, E., Whitley, C., White matter alterations in mucopolysaccharidosis type I assessed by automated DTI analysis. Mol. Genet. Metab., 120, 2017, S102.
54. Pasternak, O., Sochen, N., Gur, Y., Intrator, N., Assaf, Y., Free water elimination and mapping from diffusion MRI. Magn. Reson. Med. 62 (2009), 717–730.
55. 1H-magnetic resonance spectroscopy before and after bone marrow transplantation. Pediatr. Res. 49 (2001), 349–355.
56. Davison, J.E., Hendriksz, C.J., Sun, Y., Davies, N.P., Gissen, P., Peet, A.C., Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome). J. Inherit. Metab. Dis. 33:Suppl. 3 (2010), s395–s399.
57. Liimatainen, T., Hakkarainen, H., Mangia, S., Huttunen, J.M., Storino, C., Idiyatullin, D., Sorce, D., Garwood, M., Michaeli, S., MRI contrasts in high rank rotating frames. Magn. Reson. Med. 73 (2015), 254–262.
58. Satzer, D., DiBartolomeo, C., Ritchie, M.M., Storino, C., Liimatainen, T., Hakkarainen, H., Idiyatullin, D., Mangia, S., Michaeli, S., Parr, A.M., Low, W.C., Assessment of dysmyelination with RAFFn MRI: application to murine MPS I. PLoS One, 10, 2015, e0116788.
59. Bradley, W.G. Jr., Scalzo, D., Queralt, J., Nitz, W.N., Atkinson, D.J., Wong, P., Normal-pressure hydrocephalus: evaluation with cerebrospinal fluid flow measurements at MR imaging. Radiology 198 (1996), 523–529.
60. Zhang, H., Schneider, T., Wheeler-Kingshott, C.A., Alexander, D.C., NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. NeuroImage 61 (2012), 1000–1016.
61. Tymofiyeva, O., Hess, C.P., Ziv, E., Lee, P.N., Glass, H.C., Ferriero, D.M., Barkovich, A.J., Xu, D., A DTI-based template-free cortical connectome study of brain maturation. PLoS One, 8, 2013, e63310.